March 2023 FDA Recall Drug by Amerisource Health Services Llc
D-0536-2023 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Amerisource Health Services Llc on March 16, 2023 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0536-2023

Reason for Recall
Failed Dissolution Specifications: Out of specification dissolution results above specified values.
Initiated
03-16-2023
Reported
04-26-2023
Quantity
695 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services LLC
Nationwide in the USA
Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.

Batch or Lot Expiration Information

Lot# Lots: 1008622, 1010026, Exp 2/29/24